Alphar SRL
1.5 FTEThe score of Alphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -62 % Total assets -56 % Headcount (avg FTE) -46 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Alphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −101,511 € | ||||
| Equity | 453,289 € | ||||
| Cash | 144,088 € | ||||
| EBITDA | −93,260 € | ||||
| Total assets | 658,779 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 20 Nov 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Alphar's financial analysis
- Solvency68.8%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Alphar
Alphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.424.371
- VAT number
- BE0426424371
- Peppol
- Registered · 0208:0426424371 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 1984
- Registered office
- 1030 Schaerbeek
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Alphar (SRL) has been based in Schaerbeek since 1984, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 101,511 € and equity of 453,289 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 68.8%, above the median of its sector (32.3%).
Companies similar to Alphar
Companies in the same business, of comparable size and area, outside its group.
- Gama Medicals Wholesale of pharmaceutical and medical goods Uccle · balance sheet 595,368 €
- Aboca Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.24m
- Pharmacie Noël Wholesale of pharmaceutical and medical goods Rixensart · balance sheet 823,708 €
- Uniphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet 476,976 €
- Pharma 2424 Manufacture of pharmaceutical preparations Charleroi · balance sheet 550,405 €
- Daxant Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.04m
- Cosmex Wholesale of pharmaceutical and medical goods Tubize · balance sheet €5.20m
- Copharem Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.24m
Frequently asked questions about Alphar
What is the revenue of Alphar?
Alphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Alphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0426424371 for Alphar, if the company is VAT-registered. Its company number (CBE) is 0426.424.371.
Where is the registered office of Alphar?
According to the CBE register, the registered office of Alphar is in 1030 Schaerbeek.
What is the equity of Alphar?
At the close of the 2025 financial year, the equity of Alphar amounts to 453,289 €, a solvency of 68.8% of total assets.
How many people work at Alphar?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Alphar?
The register lists 1 active mandates at Alphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Alphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →